COVID-19
COVID-19-associated endocarditis risk ‘substantial’ in those with cocaine, opioid use disorders
COVID-19 infection more than doubles risk for a new diagnosis of endocarditis in adults with cocaine or opioid use disorder, according to data published in Molecular Psychiatry.
COVID-19 infection increases risk for incident diabetes by 64%
The risk for incident type 1 or type 2 diabetes increases after a COVID-19 infection, according to findings from a systematic review and meta-analysis published in Metabolism: Clinical and Experimental.
Symptomatic COVID-19 in first two trimesters associated with still, preterm birth risks
Among pregnant women with symptomatic COVID-19, SARS-CoV-2 infection during the first and second trimesters was associated with greater risks for stillbirth and preterm birth compared with infection during the third trimester, data show.
Postural orthostatic tachycardia syndrome post-COVID vaccination less likely vs. infection
The odds for developing new postural orthostatic tachycardia syndrome within 90 days after COVID-19 vaccination were more than five times lower compared with likelihood after SARS-CoV-2 infection, researchers reported.
Q&A: Smart mask designed to uncover respiratory diseases
A newly created smart mask can detect and decipher the difference between breathing, coughing and speaking, which researchers say can help in identifying several respiratory diseases.
Biomarkers predict thromboembolism risk, mortality among people with cancer, COVID-19
NEW ORLEANS — Patients with cancer and COVID-19 exhibited a 3% risk for thromboembolism within 30 days of their first positive test, according to study results presented at ASH Annual Meeting and Exposition.
Myopericarditis incidence related to COVID-19 vaccination remains low in young people
The incidence of myopericarditis among adolescents and young adults who received mRNA COVID-19 vaccines is very low, according to a systemic review and meta-analysis published in JAMA Pediatrics.
FDA authorizes omicron boosters for young children
The FDA on Thursday expanded its emergency use authorization of Moderna and Pfizer-BioNTech’s omicron-targeting bivalent COVID-19 boosters to include children aged as young as 6 months in the United States.
Life stressors can contribute to worsening long-COVID symptoms
Stressors in life can contribute to poor functional, cognitive and neuropsychiatric outcomes up to a year after being hospitalized with COVID-19, researchers reported in the Journal of Neurological Science.
Subtle COVID-19 lung changes found through photon-counting CT scans
Photon-counting detector CT found more subtle lung abnormalities that may indicate irreversible lung fibrosis in symptomatic patients following COVID-19 infection than conventional CT, according to a study published in Radiology.